Showing results (571-580 of 812) with videos related to
Sort By:
Pageof 82
Molecular and Cellular Endocrinology|July 31, 2021
Characterization of endogenous bile acid composition in individuals with cold-activated brown adipose tissueCarsten T Herz, Oana C Kulterer, Marlene Prager, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 27, 2019
MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATIONYvonne Winhofer, Peter Wolf, Paul Fellinger, et al.The Lancet. Gastroenterology & Hepatology|March 30, 2019
Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension studyMichael Trauner, Frederik Nevens, Mitchell L Shiffman, et al.Metabolism: Clinical and Experimental|October 1, 2014
Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patientsAlexander Wree, Martin Schlattjan, Lars P Bechmann, et al.Digestive Diseases and Sciences|March 18, 2022
Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in CirrhosisTheresa Bucsics, Katharina Lampichler, Constantin Vierziger, et al.JHEP Reports : Innovation in Hepatology|December 3, 2024
Fecal deoxycholic acid associates with diet, intestinal microbes, and total bilirubin in primary sclerosing cholangitisConnie Chan, Mateus Lemos, Peter Finnegan, et al.Gastroenterology|December 11, 2020
The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic SteatohepatitisZobair M Younossi, Quentin M Anstee, Vincent Wai-Sun Wong, et al.JHEP Reports : Innovation in Hepatology|December 21, 2023
Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortalityLukas Hartl, Benedikt Simbrunner, Mathias Jachs, et al.Frontiers in Immunology|January 10, 2022
The Tyrosine Kinase Tec Regulates Effector Th17 Differentiation, Pathogenicity, and Plasticity in T-Cell-Driven Intestinal InflammationLisa Sandner, Marlis Alteneder, Ci Zhu, et al.Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.Pageof 82